Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395692 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fatty Acid Amide Hydrolase (FAAH) (AA 480-580) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human, Rat
- Host
- Mouse
- Epitope
- AA 480-580
- Isotype
- IgG
- Antibody clone number
- 2G8
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet.
Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
[C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R
Metabolism: clinical and experimental 2011 May;60(5):730-4
Metabolism: clinical and experimental 2011 May;60(5):730-4
Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.
Deluis DA, Sagrado MG, Aller R, Izaola O, Conde R
Metabolism: clinical and experimental 2010 Sep;59(9):1387-92
Metabolism: clinical and experimental 2010 Sep;59(9):1387-92
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
[C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
De Luis DA, González Sagrado M, Aller R, Izaola O, Conde R, Romero E
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 2010 Feb;57(2):54-9
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 2010 Feb;57(2):54-9
Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M
Journal of clinical psychopharmacology 2010 Aug;30(4):441-5
Journal of clinical psychopharmacology 2010 Aug;30(4):441-5
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
